February 3, 2022 -- Waters has acquired the technology assets and intellectual property rights of Megadalton Solutions, an early-stage developer of charge detection mass spectrometry (CDMS) technology and services.
Founded in 2018, Megadalton Solutions has developed CDMS instrumentation that makes it possible to analyze extremely large proteins and protein complexes, such as those used in cell and gene therapies, that would otherwise be difficult to analyze with conventional mass spectrometry.
Waters became a strategic investor in Megadalton, and in 2021, brought its CDMS technology into the Waters Immerse Cambridge innovation and research lab for advanced testing and development. Financial details of the transaction were not disclosed.
Copyright © 2022 scienceboard.net